DPHARM 2023 underscores the promise and challenge of innovation to advance drug development. It features new models and collaborations to get therapeutics to patients faster. DPHARM is dedicated to challenging creative solutions and finding a way to implement them. DPHARM 2023 will provide a wide choice of tracks including AI/machine learning, accelerating and scaling efficiencies, innovative approaches to reduce sites/patient burden, end-to-end digital transformation, operationalizing DCTs, and more.
Senior clinical operation leadership representation from Merck, Boehringer-Ingelheim, Regeneron, Biogen, Eisai, Novo Nordisk, AbbVie and more.
Get 15% off with code MLSC15.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
